Skip to content

Fresenius Medical Care Reports Full Year 2014 Results and provides Outlook for 2015

| COM | Press release

Fresenius Medical Care has achieved its targets for the fiscal year 2014.

Net revenue of Fresenius Medical Care AG & Co. KGaA increased by 8% to $15,832 million as compared to the full year 2013.

Operating income (EBIT) for the full year 2014 remained nearly flat at $2,255 million.

Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA decreased by 6% to $1,045 million.

For the 18th consecutive year shareholders can expect to receive an increased annual dividend. At the ordinary annual general meeting to be held on May 19, 2015, shareholders will be asked to approve a dividend per share of €0.78, an increase of 1% (2013: €0.77).

The information provided is based on exchange rates prevailing at the beginning of 2015. Savings from the global efficiency program are included, while potential acquisitions are not. In addition the outlook reflects further operating cost investments within the Care Coordination segment for future growth in line with our 2020 strategy.

For the full year 2015, Fresenius Medical Care expects revenue to grow at
5-7%, which at constant currency is a growth rate of 10-12%. Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA is expected to increase 0-5%.

For the year 2016 we expect an acceleration of growth with a revenue increase of 9–12% and net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA growing by 15–20%.

As disclosed in the company’s long-term target for 2020 the company expects revenue to grow at an average annual growth rate of approx. 10% and net income attributable to shareholders in the high single digits.



Fresenius SE & Co. KGaA holds approximately 30.3% of Fresenius Medical Care AG & Co. KGaA’s capital.

Fresenius Medical Care AG & Co. KGaA
Represented by Fresenius Medical Care Management AG
Represented by its management board
Bad Homburg v.d.H., February 25, 2015